MENU
+Compare
UNBX
Stock ticker: OTC
AS OF
Aug 8 closing price
Price
$0.07
Change
-$0.01 (-12.50%)
Capitalization
1.2M

UNBX Unity Biotechnology, Inc. Forecast, Technical & Fundamental Analysis

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging... Show more

Industry: #Biotechnology
UNBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for UNBX with price predictions
Aug 08, 2025

Momentum Indicator for UNBX turns negative, indicating new downward trend

UNBX saw its Momentum Indicator move below the 0 level on July 29, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 80 similar instances where the indicator turned negative. In of the 80 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UNBX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for UNBX entered a downward trend on August 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for UNBX's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 67 cases where UNBX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for UNBX just turned positive on July 23, 2025. Looking at past instances where UNBX's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

Following a +6 3-day Advance, the price is estimated to grow further. Considering data from situations where UNBX advanced for three days, in of 236 cases, the price rose further within the following month. The odds of a continued upward trend are .

UNBX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (18.662). P/E Ratio (0.000) is within average values for comparable stocks, (54.033). UNBX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.909). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (286.048).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. UNBX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UNBX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
UNBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a r&d company of therapeutics to extend the human healthspan

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COHR115.441.62
+1.42%
Coherent Corp
TRAW1.500.02
+1.35%
Traws Pharma Inc
CVBF18.85-0.18
-0.95%
CVB Financial Corp
BLDP1.80-0.03
-1.64%
Ballard Power Systems
NNBR2.12-0.08
-3.64%
NN

UNBX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, UNBX has been loosely correlated with INMB. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if UNBX jumps, then INMB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UNBX
1D Price
Change %
UNBX100%
-15.66%
INMB - UNBX
54%
Loosely correlated
-8.24%
OGEN - UNBX
36%
Loosely correlated
-10.77%
HOFBF - UNBX
34%
Loosely correlated
N/A
ABCL - UNBX
30%
Poorly correlated
+0.24%
CLLS - UNBX
29%
Poorly correlated
-4.06%
More